Table 1 Experimental subject description of healthy and ischemic heart disease (diastolic and systolic) of serum samples.

From: Understanding of metals dysregulation in patients with systolic and diastolic dysfunction in ischemic heart disease

Patient characteristics

Disease

Healthy

p-value

Number of samples

62

55

Gender (male/female)

54/8

44/11

Age male (years; µ ± σ)

58.90 ± 8.34

31.3 ± 6.41

2 × 10–33

Age female (years; µ ± σ)

58.12 ± 9.51

30.18 ± 9.03

3 × 10–5

Height (cm)

163.80 ± 8.91

167.32 ± 7.95

0.0649

Body weight (Kg)

72.41 ± 11.94

65.49 ± 6.99

8 × 10–5

BMI (Kg/m2)

26.66 ± 4.83

23.59 ± 3.64

0.0007

SBP (mm Hg)

129.46 ± 18.60

112.91 ± 10.48

1 × 10–7

DBP (mm Hg)

75.67 ± 9.69

72.27 ± 8.65

0.0394

Medical history

Frequency

Diabetes/non-diabetes

37/25

0/55

 

Hypertension/non-hypertension

41/21

0/55

 

Chest pain/non-chest pain

48/14

0/55

 

Current smoker/non-smokers

11/51

0/55

 

Hypercholesterolemia/non-hypercholesterolemia

6/56

0/55

 

Echocardiographic parameters

Ejection fraction (< 45%/ > 45%)

12/50

 

Grades 0–1/1A and 2)

45/4/and 5

 

E/e′ (< 8/9–15 and > 15)

12/33 and 7

 

Biochemical parameters

Creatinine (mg/dl)

0.99 ± 0.26

 

BUN (mg/dl)

17.74 ± 7.85

 

Random blood glucose (mg/dl)

183.67 ± 64.81

 

Fasting blood glucose (mg/dl)

164.96 ± 57.98

 
  1. µ mean, σ standard deviation, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, BUN blood urea nitrogen.